Combinatorial therapies of Cancer Immunotherapies and Oncolytic Virotherapy in Creative Biolabs
Oct 16, 2019
Supported by leading technologies along with experienced senior scientists majored in cancer therapy, Creative Biolabs specializes in combinatorial therapy services of oncolytic viruses and cancer immunotherapies on the basis of self-developed cancer therapy platforms.
New York, United States - October 16, 2019 /MarketersMedia/ —
Supported by leading technologies along with experienced senior scientists majored in cancer therapy, Creative Biolabs specializes in combinatorial therapy services of oncolytic viruses and cancer immunotherapies on the basis of self-developed cancer therapy platforms.
Immunotherapy has achieved remarkable clinical results in the last few years while oncolytic virus (OV), a replication virus which selectively invades cancer cells, have long been acknowledged to be effective in anti-cancer approaches. Recent research showed that OVs can function as an adjuvant to other immunotherapies, including cancer vaccines, cytokines, immune checkpoint inhibitors, etc. With a lot of past experience in oncolytic viruses as well as our highly qualified OncoVirapy™, Creative Biolabs has equipped itself with rich experience on oncolytic virotherapy development for combination therapy with cancer immunotherapy as mentioned above.
· Combination with Adoptive T Cell Therapy (ACT)
OVs can regulate the immune system as well as the local tumor microenvironment, thus to augment the effect of ACT. Creative Biolabs owns a well-performed immunotherapy platform to deliver services of combining oncolytic virotherapy with ATC transfer therapy, including tumor-infiltrating lymphocyte therapy (TIL) , cytokine-induced killer cell immunotherapy (DC-CIK), T-cell receptor-engineered T cells therapy(TCR-T), chimeric antigen receptor T-cell therapy (CAR-T), and dendritic cell therapy. A considerable variety of animal models with severe immune system function defects are also provided.
· Combination with Immune Checkpoint Inhibitors (ICIs)
The combination therapies of ICIs and OVs are attractive since OVs help to increase T cell recruitment and activate immune cells. Experts of Creative Biolabs have developed a wide range of ICIs and built several combination therapy platforms which are potentially suitable to achieve successful combination. Combination of OVs and ICIs services are offered, including assay development for OVs combined with ICIs, arming oncolytic virus with ICIs Payload, etc.
· Combination with Cytokines
Encoded by small genes and easy to build in oncolytic viral genomes, the cooperation of cytokines and OVs greatly intensifies responsiveness of treatment. Creative Biolabs is well-versed in combination therapy of oncolytic virus armed with cytokines. Combination of oncolytic virotherapy and cytokines services are provided including colony-stimulating factors (CSFs), interferons (IFNs), interleukin (IL), chemokines, etc. Owning one of the world’s most comprehensive cytokines products and research techniques, Creative Biolabs will offer the most suitable scheme according to clients’ research demand.
· Other Combination Therapies
Creative Biolabs has also developed scientific and efficient combination therapy platforms which contain various oncolytic virus, a wind range of chemotherapy drugs, varied OV vaccines and method of radiation therapy to fit types of disease, including tumor-associated antigen (TAA)-encoding OVs, heterologous virus prime-boost for cancer vaccination, OVs combined with radiation therapy and chemotherapy drugs combined with OVs, etc.
Aforementioned services can all be found at Creative Biolabs, and more customized services concerned with oncolytic viruses are also provided. More detailed information can be found at https://www.creative-biolabs.com/oncolytic-virus
About Creative Biolabs
Creative Biolabs is one of the recognized leaders in the field of oncolytic virotherapy development for combinatorial therapy with cancer immunotherapy. Supported by experienced scientists who have developed a complete set of in vitro and in vivo assays, the products cover adenovirus, vesicular stomatitis virus and OVs with specific modifications such as cytokine-armed OV, capsid-modified OV, reporter-encoding OV, etc. Creative Biolabs promises to provide efficient, normative and all-inclusive oncolytic virus therapy development services for clients worldwide.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/oncolytic-virus
Source: MarketersMedia
Release ID: 88928372
More News
Penalty kings progress in FA Trophy
The third qualifying round of the FA Trophy was dominated by penalty shoot-outs.
Football fixtures and results
Catch up with all the week’s football fixtures and results here.
Kent clinch promotion!
Kent have claimed County Championship Division 1 promotion under head coach Adam Hollioake and skipper Daniel Bell-Drummond.
Report: Painful day for well-beaten Gillingham
Gillingham’s winning streak in League Two came to an abrupt end on Saturday against an impressive York City.
Gillingham add new keeper to squad for York trip
Gillingham had a new face in the squad on Saturday for their League Two game at York City.
Matchday Live: York v Gillingham, Tonbridge v Ebbsfleet, Maidstone v Truro
Follow this afternoon’s football, including Gillingham’s trip to York, in our live blog.
Compton’s century edges Kent towards promotion
Kent took a tentative stride towards promotion from Division 2 of the County Championship on day two of their game with Gloucestershire at Canterbury.
All-rounder awarded county cap
Grant Stewart has been awarded his long-awaited Kent county cap.
Kent start reply strongly after bowling out visitors
Kent moved a step closer to claiming promotion from Division 2 of the County Championship on Thursday.
Gillingham boss Ainsworth issues York warning after flying start
Gillingham’s impressive run faces a major test on Saturday as they travel to a York City side yet to lose at home in League Two.
Jonny Williams starts new chapter in the National League after Gillingham exit
Former Gillingham midfielder Jonny Williams has ended his search for a new club and will be playing National League football this season.
Eli King: Why I chose Gillingham after having just hours to decide
Eli King admits it has been a “whirlwind” since his last-minute decision to join Gillingham, but he already feels at home.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.